cytosine has been researched along with Ovarian Neoplasms in 14 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of DNA methylation in epithelial ovarian cancer (EOC) is not fully understood." | 1.42 | Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer. ( Li, PL; Wang, TZ; Zhang, LY; Zhang, XC, 2015) |
| "Down-regulation of miR-130b in ovarian cancer was associated with FIGO III-IV clinical stages and poorer histological differentiation." | 1.38 | Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. ( Cai, J; Cao, J; Tang, H; Wang, Q; Wang, Z; Wu, L; Yang, C, 2012) |
| "Many patients with ovarian cancer disease relapse within 6 months after adjuvant chemotherapy, with a limited prognosis." | 1.37 | Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles. ( Ammerpohl, O; Arnold, N; Bauerschlag, DO; Bräutigam, K; Hilpert, F; Lin, Q; Maass, N; Meinhold-Heerlein, I; Schem, C; Wagner, W; Weigel, MT, 2011) |
| "A series of 214 cases with familial breast cancer were analysed using this approach; 88/214 were heterozygous for the promoter polymorphism, thereby excluding a deletion in this region." | 1.30 | Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. ( Brown, MA; Catteau, A; Dunning, AM; Greenman, J; Hodgson, S; Mathew, CG; Solomon, E; Xu, CF, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D | 1 |
| Wu, Y | 1 |
| Tilley, RD | 1 |
| Gooding, JJ | 1 |
| Kweon, J | 1 |
| Jang, AH | 1 |
| Shin, HR | 1 |
| See, JE | 1 |
| Lee, W | 1 |
| Lee, JW | 1 |
| Chang, S | 1 |
| Kim, K | 1 |
| Kim, Y | 1 |
| Zhang, LY | 1 |
| Li, PL | 1 |
| Wang, TZ | 1 |
| Zhang, XC | 1 |
| Bauerschlag, DO | 1 |
| Ammerpohl, O | 1 |
| Bräutigam, K | 1 |
| Schem, C | 1 |
| Lin, Q | 1 |
| Weigel, MT | 1 |
| Hilpert, F | 1 |
| Arnold, N | 1 |
| Maass, N | 1 |
| Meinhold-Heerlein, I | 1 |
| Wagner, W | 1 |
| Yang, C | 1 |
| Cai, J | 1 |
| Wang, Q | 1 |
| Tang, H | 1 |
| Cao, J | 1 |
| Wu, L | 1 |
| Wang, Z | 1 |
| Wang, Y | 1 |
| Kringen, P | 1 |
| Kristensen, GB | 1 |
| Holm, R | 1 |
| Baekelandt, MM | 1 |
| Olivier, M | 1 |
| Skomedal, H | 1 |
| Hainaut, P | 1 |
| Tropé, CG | 1 |
| Abeler, VM | 1 |
| Nesland, JM | 1 |
| Børresen-Dale, AL | 1 |
| Helland, A | 1 |
| Gekeler, V | 1 |
| Gimmnich, P | 1 |
| Hofmann, HP | 1 |
| Grebe, C | 1 |
| Römmele, M | 1 |
| Leja, A | 1 |
| Baudler, M | 1 |
| Benimetskaya, L | 1 |
| Gonser, B | 1 |
| Pieles, U | 1 |
| Maier, T | 1 |
| Wagner, T | 1 |
| Sanders, K | 1 |
| Beck, JF | 1 |
| Hanauer, G | 1 |
| Stein, CA | 1 |
| Galmarini, CM | 1 |
| Li, AJ | 1 |
| Scoles, DR | 1 |
| Armstrong, KU | 1 |
| Karlan, BY | 1 |
| Burchenal, JH | 1 |
| King, BL | 1 |
| Peng, HQ | 1 |
| Goss, P | 1 |
| Huan, S | 1 |
| Bronson, D | 1 |
| Kacinski, BM | 1 |
| Hogg, D | 1 |
| Siu, LL | 1 |
| Attardo, G | 1 |
| Izbicka, E | 1 |
| Lawrence, R | 1 |
| Cerna, C | 1 |
| Gomez, L | 1 |
| Davidson, K | 1 |
| Finkle, C | 1 |
| Marsolais, C | 1 |
| Rowinsky, EK | 1 |
| Von Hoff, DD | 1 |
| Qu, G | 1 |
| Dubeau, L | 1 |
| Narayan, A | 1 |
| Yu, MC | 1 |
| Ehrlich, M | 1 |
| Catteau, A | 1 |
| Xu, CF | 1 |
| Brown, MA | 1 |
| Hodgson, S | 1 |
| Greenman, J | 1 |
| Mathew, CG | 1 |
| Dunning, AM | 1 |
| Solomon, E | 1 |
14 other studies available for cytosine and Ovarian Neoplasms
| Article | Year |
|---|---|
Rapid and ultrasensitive electrochemical detection of DNA methylation for ovarian cancer diagnosis.
Topics: Biosensing Techniques; Cytosine; DNA; DNA Methylation; Electrochemical Techniques; Gold; Humans; Met | 2022 |
A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.
Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Survival; CRISPR-Cas Systems; Cytosine; DNA | 2020 |
Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Case-Control Studie | 2015 |
Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles.
Topics: Chemotherapy, Adjuvant; Cytosine; Disease-Free Survival; DNA Methylation; Female; Humans; Microarray | 2011 |
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Topics: Cell Line, Tumor; CpG Islands; Cytosine; DNA Methylation; Down-Regulation; Drug Resistance, Multiple | 2012 |
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Codon; Cohort Studie | 2004 |
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; B-Lymphocytes; Carcinoma; Ce | 2006 |
Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Carcinoma, Non-S | 2006 |
Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Topics: Adenine; Alleles; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytosine; ErbB Receptors; Female; | 2008 |
Geographic chemotherapy--Burkitt's tumor as a stalking horse for leukemia: presidential address.
Topics: Adult; Africa; Antineoplastic Agents; Child; Cytosine; Female; Follow-Up Studies; Geography; Humans; | 1966 |
Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families.
Topics: Adenine; Autoradiography; Cytosine; DNA, Neoplasm; Female; Guanine; Humans; Male; Oligonucleotide Pr | 1997 |
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units.
Topics: Antineoplastic Agents; Cytosine; Dioxolanes; Female; Humans; Kidney Neoplasms; Melanoma; Ovarian Neo | 1998 |
Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.
Topics: 5-Methylcytosine; Carcinoma; Cell Transformation, Neoplastic; Centromere; Chromosomes, Human, Pair 1 | 1999 |
Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions.
Topics: Adenocarcinoma; Adult; Age of Onset; Base Sequence; Breast Neoplasms; Cytosine; DNA; DNA, Neoplasm; | 1999 |